Alexis Buffington, DO
Dermatology · Dearborn, MINPI 1407389406
Payments from drug & device makers
Across 293 payments — averaging $26.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Regeneron Healthcare Solutions, Inc.$810
- Sun Pharmaceutical Industries Inc.$689
- Arcutis Biotherapeutics, Inc.$579
- Dermavant Sciences, Inc.$549
- UCB, Inc.$473
- plus $3K from 18 others
What the payments were for
- Food & beverage$7,31696%
- Education$3124%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $1,203 |
| Regeneron Healthcare Solutions, Inc. | 22 | $810 |
| Sun Pharmaceutical Industries Inc. | 28 | $689 |
| Arcutis Biotherapeutics, Inc. | 45 | $579 |
| Dermavant Sciences, Inc. | 17 | $549 |
| UCB, Inc. | 21 | $473 |
| Sanofi | 8 | $423 |
| Johnson & Johnson | 12 | $401 |
| Novartis | 13 | $383 |
| Pfizer | 13 | $352 |
| Lilly USA, LLC | 7 | $343 |
| Galderma Laboratories, L.p. | 23 | $304 |
| Janssen Scientific Affairs, LLC | 2 | $243 |
| Amgen | 10 | $207 |
| Incyte Corporation | 4 | $192 |
| E.r. Squibb & Sons, L.L.C. | 7 | $136 |
| Boehringer Ingelheim | 1 | $108 |
| Organon | 5 | $68 |
| LEO Pharma Inc. | 3 | $57 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $36 |
| Biofrontera Inc. | 3 | $26 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Almirall LLC | 1 | $14 |
| Biodermis LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,628 in reported general payments places this provider in the 70th percentile of 404 dermatology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 11 | $40,999 |
| Tacrolimus | 27 | $2,205 |
| Clobetasol Propionate | 28 | $1,487 |
| Clindamycin Phosphate | 31 | $1,229 |
| Fluocinonide | 27 | $938 |
| Ketoconazole | 75 | $907 |
| Fluorouracil | 15 | $861 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 12 | $508 |
| Triamcinolone Acetonide | 75 | $463 |
| Ammonium Lactate | 13 | $301 |
| CiclopiroxCiclopirox Olamine | 33 | $278 |
| Mometasone Furoate | 15 | $243 |
| Hydrocortisone | 26 | $116 |
| Mupirocin | 16 | $90 |
| Minoxidil | 11 | $38 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Dearborn
- Steven DaveluyDearborn$689K
- Michael GoldfarbDearborn$532K
- Johann GudjonssonAnn Arbor$15.9M
- Ali MoiinTroy$9.9M
- Linda Stein GoldWest Bloomfield$7.5M
- Wendy McFaldaClarkston$3.6M
- Kristi HawleyCaledonia$2.5M
- Brent BoyceSebewaing$2.2M
- David AltmanWarren$1.9M
- Christofer BuattiAuburn Hills$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.